These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 32579190)
1. Colchicine for the Treatment of Myocardial Injury in Patients With Coronavirus Disease 2019 (COVID-19)-An Old Drug With New Life? Rabbani AB; Parikh RV; Rafique AM JAMA Netw Open; 2020 Jun; 3(6):e2013556. PubMed ID: 32579190 [No Abstract] [Full Text] [Related]
2. Why not to use colchicine in COVID-19? An oldanti-inflammatory drug for a novel auto-inflammatory disease. Piantoni S; Patroni A; Toniati P; Furloni R; Franceschini F; Andreoli L; Scarsi M Rheumatology (Oxford); 2020 Jul; 59(7):1769-1770. PubMed ID: 32472681 [No Abstract] [Full Text] [Related]
3. Can Colchicine as an Old Anti-Inflammatory Agent Be Effective in COVID-19? Nasiripour S; Zamani F; Farasatinasab M J Clin Pharmacol; 2020 Jul; 60(7):828-829. PubMed ID: 32445400 [No Abstract] [Full Text] [Related]
4. Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality. Bonow RO; Fonarow GC; O'Gara PT; Yancy CW JAMA Cardiol; 2020 Jul; 5(7):751-753. PubMed ID: 32219362 [No Abstract] [Full Text] [Related]
5. Myocardial injury in severe COVID-19 infection. Jaffe AS; Cleland JGF; Katus HA Eur Heart J; 2020 Jun; 41(22):2080-2082. PubMed ID: 32464642 [No Abstract] [Full Text] [Related]
6. Myocardial Injury in COVID-19-Can We Successfully Target Inflammation? Giannopoulos G; Vrachatis DA; Deftereos SG JAMA Cardiol; 2020 Sep; 5(9):1069-1070. PubMed ID: 32936267 [No Abstract] [Full Text] [Related]
7. [DZK Recommendations for Tuberculosis, BCG and COVID-19 in Germany - (Official Abbreviation of Coronavirus Disease 2019 Caused by the New Coronavirus SARS-CoV-2)]. Otto-Knapp R; Häcker B; Breuer C; Diel R; Kaufmann SHE; Korr G; Pfeiffer M; Schaberg T; Schönfeld N; Witte P; Bauer T Pneumologie; 2020 Jul; 74(7):412-416. PubMed ID: 32674189 [No Abstract] [Full Text] [Related]
8. Implications for the Care of Patients With COVID-19 and Inflammatory Myocardial Disease. Di Tano G; Iacovoni A; De Maria R JAMA Cardiol; 2020 Nov; 5(11):1305-1306. PubMed ID: 32822458 [No Abstract] [Full Text] [Related]
9. Myocardial Injury in COVID-19 Patients: The Beginning or the End? Uriel N; Sayer G; Clerkin KJ J Am Coll Cardiol; 2020 Aug; 76(5):547-549. PubMed ID: 32731932 [TBL] [Abstract][Full Text] [Related]
10. [Analysis of coronavirus disease-19 (COVID-19) based on SARS autopsy]. Ding YQ; Bian XW Zhonghua Bing Li Xue Za Zhi; 2020 Apr; 49(4):291-293. PubMed ID: 32268662 [TBL] [Abstract][Full Text] [Related]
11. Treatments for COVID-19: emerging drugs against the coronavirus. Khademolhosseini S; Kavandi H; Ghaffari S Acta Biomed; 2020 Jun; 91(3):ahead of print. PubMed ID: 32921740 [TBL] [Abstract][Full Text] [Related]
12. The Impact of COVID-19 on Italy: A Lesson for the Future. Santacroce L; Bottalico L; Charitos IA Int J Occup Environ Med; 2020 Jul; 11(3):151-152. PubMed ID: 32225178 [No Abstract] [Full Text] [Related]
13. IL-6 may be a good biomarker for earlier detection of COVID-19 progression. Wang C; Fei D; Li X; Zhao M; Yu K Intensive Care Med; 2020 Jul; 46(7):1475-1476. PubMed ID: 32385523 [No Abstract] [Full Text] [Related]
14. Treatments for COVID-19: emerging drugs against the coronavirus - reply. Potì F Acta Biomed; 2020 Jun; 91(3):ahead of print. PubMed ID: 32921741 [No Abstract] [Full Text] [Related]
15. [Determination Methods of 2019 Novel Coronavirus (SARS-CoV-2)]. Pan X; Yao Y; Cao C; Huang Y; Wu J Zhongguo Yi Liao Qi Xie Za Zhi; 2020 Apr; 44(4):359-362. PubMed ID: 32762214 [TBL] [Abstract][Full Text] [Related]
16. Errors in Tracing Coronavirus SARS-CoV-2 Transmission Using a Maximum Likelihood Tree. Comment on "A Snapshot of SARS-CoV-2 Genome Availability up to April 2020 and its Implications: Data Analysis". Forster P; Forster L JMIR Public Health Surveill; 2020 Nov; 6(4):e23542. PubMed ID: 33174859 [No Abstract] [Full Text] [Related]